Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
Translational Model to Predict Pulmonary Pharmacokinetics and Efficacy in Man for Inhaled Bronchodilators
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-077-Monday
- By: HENDRICKX, Adriaan (AstraZeneca, DMPK, Mölndal, Sweden)
- Co-author(s): Adriaan Hendrickx: RIA DMPK, AstraZeneca, Mölndal, Sweden
Eva Lamm Bergström: RIA DMPK, AstraZeneca, Mölndal, Sweden
David L. I. Janzén: CVMD DMPK, AstraZeneca, Mölndal, Sweden
Markus Fridén: RIA DMPK, AstraZeneca, Mölndal, Sweden
Ulf Eriksson: RIA QCP, AstraZeneca, Mölndal, Sweden
Ken Grime: RIA DMPK, AstraZeneca, Mölndal, Sweden
Douglas Ferguson: Oncology DMPK, AstraZeneca, Mölndal, Sweden - Abstract:
Backgrounds
Inhaled drug therapy is typically used for targeting the lung whilst minimizing systemic exposure in order to improve the benefit/risk margin for treatments of respiratory disease.
Aims
The aim of current study was to develop a translational modelling framework for capturing both lung and systemic PK and efficacy after pulmonary delivery.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023